The ProHear Study found that the drug candidate Bimokalner produced a clinically meaningful reduction in pure-tone audiometry threshold shifts in testicular cancer patients who developed cisplatin-induced ototoxicity.
From building rapport to leveraging technology, HCPs share creative strategies to keep kids engaged for successful pediatric testing.
The 41st annual event will gather hearing health professionals, manufacturers, and advocates to discuss the latest in hearing assistive technology and advocacy from June 10–12, 2026.
Sensorion is focusing on SENS-601 targeting GJB2 mutations, while discontinuing development of its OTOF-targeting program, SENS-501.
The company’s OtoKiosk digital audiometer and Amplifon App were recognized by the UX Design Awards and iF Design Awards for user experience and innovation.
Auditdata has launched a brief industry-wide survey to gather insights from hearing care professionals on staffing challenges, administrative workload, clinician burnout, and potential solutions to improve clinic efficiency.
